Found: 47
Select item for more details and to access through your institution.
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 22, p. 3663, doi. 10.3390/cells11223663
- By:
- Publication type:
- Article
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group.
- Published in:
- Clinical Colorectal Cancer, 2022, v. 21, n. 3, p. 188, doi. 10.1016/j.clcc.2022.04.001
- By:
- Publication type:
- Article
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Pilot Study Assessing the Incidence and Clinical Significance of Circulating Tumor Cells in Esophagogastric Cancers.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 2, p. 94, doi. 10.1016/j.clcc.2013.11.003
- By:
- Publication type:
- Article
Case Report of Acute Aortic Dissection during Treatment with Capecitabine for a Late Recurrence of Breast Cancer.
- Published in:
- Chemotherapy (0009-3157), 2010, v. 56, n. 3, p. 203, doi. 10.1159/000316331
- By:
- Publication type:
- Article
Retrospective Evaluation of the Prognostic Value of Histological Growth Pattern in Patients with Colorectal Peritoneal Metastases Undergoing Curative-Intent Cytoreductive Surgery.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 6, p. 3778, doi. 10.1245/s10434-024-15125-y
- By:
- Publication type:
- Article
ASO Visual Abstract: The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases—A Pilot Study.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 6, p. 3320, doi. 10.1245/s10434-023-13118-x
- By:
- Publication type:
- Article
Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 3, p. 1863, doi. 10.1245/s10434-022-12736-1
- By:
- Publication type:
- Article
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.
- Published in:
- Archivum Immunologiae & Therapiae Experimentalis, 2021, v. 69, n. 1, p. 1, doi. 10.1007/s00005-021-00605-w
- By:
- Publication type:
- Article
The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 442, doi. 10.1038/s41416-023-02524-3
- By:
- Publication type:
- Article
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
- Published in:
- British Journal of Cancer, 2021, v. 125, n. 7, p. 911, doi. 10.1038/s41416-021-01474-y
- By:
- Publication type:
- Article
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Erratum to: Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review.
- Published in:
- Journal of Surgical Oncology, 2019, v. 119, n. 4, p. 489, doi. 10.1002/jso.25320
- By:
- Publication type:
- Article
Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 4, p. 621, doi. 10.1007/s10120-013-0328-9
- By:
- Publication type:
- Article
Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 5, p. 505, doi. 10.1093/jnci/djad030
- By:
- Publication type:
- Article
Response.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju121
- By:
- Publication type:
- Article
Systemic Therapies for Advanced Squamous Cell Anal Cancer.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 7, p. 1, doi. 10.1007/s11912-018-0698-6
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.245357
- By:
- Publication type:
- Article
Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 728, doi. 10.1634/theoncologist.2016-0396
- By:
- Publication type:
- Article
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 402, doi. 10.1634/theoncologist.2016-0241
- By:
- Publication type:
- Article
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.
- Published in:
- Carcinogenesis, 2016, v. 37, n. 9, p. 852, doi. 10.1093/carcin/bgw073
- By:
- Publication type:
- Article
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27099-6
- By:
- Publication type:
- Article
Anti-angiogenic therapies for advanced esophago-gastric cancer.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2014, v. 35, n. 4, p. 253, doi. 10.4103/0971-5851.144985
- By:
- Publication type:
- Article
Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 11, p. e2024406, doi. 10.1001/jamanetworkopen.2020.24406
- By:
- Publication type:
- Article
An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumab.
- Published in:
- International Journal of Biological Markers, 2015, v. 30, n. 1, p. e73, doi. 10.5301/jbm.5000097
- By:
- Publication type:
- Article
PD-L1 Expression in Paired Samples of Rectal Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2606, doi. 10.3390/cancers16142606
- By:
- Publication type:
- Article
Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5823, doi. 10.3390/cancers15245823
- By:
- Publication type:
- Article
Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6361, doi. 10.3390/cancers13246361
- By:
- Publication type:
- Article
Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4506, doi. 10.3390/cancers13184506
- By:
- Publication type:
- Article
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18 F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2752, doi. 10.3390/cancers12102752
- By:
- Publication type:
- Article
Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1014-6
- By:
- Publication type:
- Article
Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 136, n. 3, p. 717, doi. 10.1007/s10549-012-2260-9
- By:
- Publication type:
- Article
Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors.
- Published in:
- OncoTargets & Therapy, 2014, v. 7, p. 1001, doi. 10.2147/OTT.S44941
- By:
- Publication type:
- Article
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 1, p. 94, doi. 10.1002/ijc.32507
- By:
- Publication type:
- Article
Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.
- Published in:
- International Journal of Cancer, 2017, v. 140, n. 2, p. 431, doi. 10.1002/ijc.30453
- By:
- Publication type:
- Article
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article